Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
Status:
Withdrawn
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test whether treatment with isosorbide mononitrate
will improve left ventricular hypertrophy ("thickening") which puts people at risk for
developing heart failure. Once it develops, heart failure is a very serious condition and
thus it is important to find ways to prevent it from happening. The investigators have
reasons to believe that dilating the blood vessels with this specific medication will improve
the thickening of the heart, which increases the risk of heart failure.